Report: RFK Jr. Proposes FDA Relax Oversight of Unproven Peptides

According to a report cited by Ars Technica, Health Secretary Robert F. Kennedy Jr. has proposed that the FDA take a more lenient approach toward peptide products that lack proof of safety and effectiveness. FDA scientists reportedly stated that none of the popular peptide drugs in question have been established as safe or effective. The proposal has raised concerns among regulators about whether consumers could be exposed to unverified treatments. The report does not detail a final decision, and the proposal's status remains unclear from the available coverage.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in